Search Results

Blood Cancer Patients Need Support Now More Than Ever

(Rye Brook, NY, Sept. , ) — Having blood cancer is tough. Having blood cancer now is even tougher. Blood Cancer Awareness Month in September provides …

Managing blood cancer treatment side effects in young adults

Treatment side effects may last well after treatment is completed or may be permanent. 

Lessons in Blood Cancer: How Far We Have Come

The Leukemia & Lymphoma Society® is now Blood Cancer United®

Today, The Leukemia & Lymphoma Society—now Blood Cancer United—unveiled its first national advertising campaign in more than a decade.

Continued Collaboration Fuels Hope for Rare Blood Cancer Treatments

The Hairy Cell Leukemia Foundation (HCLF) and The Leukemia & Lymphoma Society, now Blood Cancer United, have renewed their partnership to support the …

Managing school during blood cancer treatment as a young adult

If you are a student, you may need to take a medical leave of absence. Talk to your healthcare team to make the decision best for you.

Blood cancers that cause high monocytes: Understanding the connection

Table of contents:What are monocytes?​Monocyte ranges​What causes monocyte levels to be higher than expected?​What blood cancers cause high monocytes?…

Cancer Patients Cheer Senate Passage of Landmark Health Reforms

“We’re elated for—and alongside—cancer patients who have been advocating for these reforms for years,” said Gwen Nichols, M.D., LLS Chief Medical Offi…

What’s Next in Blood Cancer: Looking Ahead to 2023

The most important blood cancer scientific meeting, the American Society of Hematology (ASH), is held every December. This meeting, followed closely b…

Join Us in Supporting Childhood Cancer Patients in Ukraine

As a healthcare organization dedicated to supporting all blood cancer patients, we at The Leukemia & Lymphoma Society (LLS) are horrified by the dire …

Sports Analytics Model Adapted to Improve Cancer Outcome Prediction

Outcome prediction is central to the care of cancer patients. Will the patient be at some point in the near future or succumb to the disease? Will th…

Dare to Dream Project: Treating kids with blood cancer

Blood Cancer United Condemns Federal Guidance on Medical Debt

WASHINGTON, Oct , —Today, the Trump Administration released new guidance that attempts to thwart state efforts to protect patients from the harms of m…

Suggested Reading - How to Cope Better When Someone You Love Has Cancer

In , Dr. William Penzer, a psychologist for more than forty years, found himself sitting with his wife in the waiting room of Memorial Cancer Center.…

211Astatine-CD123 Radioimmunotherapy for Cancer (Stem) Cell-Directed Treatment of Acute Leukemia

Because acute leukemias are very sensitive to radiation, radioisotopes are ideal payloads to arm antibodies against these , aggressive blood cancers. …

A phase 1/2 study of BI-1206, a monoclonal antibody to CD32b (FcyRIIB), in combination with rituximab and acalabrutinib in patients with indolent NHL that has relapsed or is refractory to rituximab

In January , LLS made an equity investment in BioInvent to "Support Clinical Development of for NHL Indications and for Lymphoma Indications Includ…

Suggested Reading - When a Parent Has Cancer: A Guide to Caring for Your Children

Advice for parents who are raising children while at the same time coping with a illness. Includes a special book for children: Becky and the Worry C…

Suggested Reading - The Human Side of Cancer: Living with Hope, Coping with Uncertainty

Provides practical and compassionate guidance for dealing with the uncertainty of a cancer diagnosis. Dr. Holland, who chaired the Department Psychiat…

Glycotyping as a novel approach to study leukemia stem cell heterogeneity and function

Leukemia stem cells (LSCs) are highly heterogeneous populations and key contributors to AML progression. Here, I aim to employ heparan sulfate (HS) gl…

KT1, a novel NK trispecific antibody for the treatment of AML and MDS

New treatments for AML and MDS are urgently needed. We have developed and performed preliminary testing of a novel, , trispecific NK cell engager name…

The Bloodline is here! LLS launches new podcasts for patients and caregivers.

Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis comes ho…

LLS Announces New Chief Operating Officer, Chief Marketing Officer and General Counsel

Global leader in the fight to end cancer welcomes leading industry experts in its commitment to finding cures.

Impaired dynamic nucleosome remodeling as a leukemogenic mechanism and therapeutic target in AML

The cohesin and BAF complexes are both epigenetic regulators of dynamic chromatin accessibility. Recurrent mutations are observed in proteins of both …

Investigating and targeting the histone acetylation reader protein ENL in acute leukemias

Leukemia often results from aberrant gene expression caused by epigenetic alterations. Previously we discovered a novel histone acetylation reader dom…

Inflammation-responsive mechanisms of malignant stem cell generation and eradication in multiple myeloma

The focus of my research is to elucidate the core molecular regulators of malignant stem cell generation in multiple myeloma. My approach addresses th…